Dacita Suen

1.3k total citations
41 papers, 980 citations indexed

About

Dacita Suen is a scholar working on Oncology, General Health Professions and Cancer Research. According to data from OpenAlex, Dacita Suen has authored 41 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 11 papers in General Health Professions and 11 papers in Cancer Research. Recurrent topics in Dacita Suen's work include Cancer survivorship and care (12 papers), Patient-Provider Communication in Healthcare (11 papers) and Breast Cancer Treatment Studies (10 papers). Dacita Suen is often cited by papers focused on Cancer survivorship and care (12 papers), Patient-Provider Communication in Healthcare (11 papers) and Breast Cancer Treatment Studies (10 papers). Dacita Suen collaborates with scholars based in China, Hong Kong and Australia. Dacita Suen's co-authors include Ava Kwong, Wwt Lam, Richard Fielding, Amy Or, Miranda Chan, Janice Tsang, Winnie Yeo, Inda Soong, Joyce Suen and Alice Ng and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgical Oncology and Biomedicine & Pharmacotherapy.

In The Last Decade

Dacita Suen

38 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dacita Suen China 19 552 304 302 236 153 41 980
M. Stead United Kingdom 15 732 1.3× 242 0.8× 210 0.7× 223 0.9× 183 1.2× 17 1.3k
Inda Soong China 18 540 1.0× 173 0.6× 125 0.4× 200 0.8× 138 0.9× 42 893
Jimmy Hwang United States 16 272 0.5× 172 0.6× 150 0.5× 87 0.4× 187 1.2× 38 882
Elyse Shuk United States 22 236 0.4× 352 1.2× 178 0.6× 195 0.8× 241 1.6× 44 1.1k
Christopher Holcombe United Kingdom 18 285 0.5× 241 0.8× 359 1.2× 173 0.7× 105 0.7× 49 1.0k
Karen Desmond United States 5 781 1.4× 175 0.6× 76 0.3× 315 1.3× 254 1.7× 16 1.1k
Esmé Finlay United States 12 331 0.6× 530 1.7× 229 0.8× 84 0.4× 271 1.8× 23 1.0k
Iman K. Martin United States 14 330 0.6× 204 0.7× 118 0.4× 76 0.3× 65 0.4× 21 1.1k
Cindy Melancon United States 10 500 0.9× 148 0.5× 94 0.3× 287 1.2× 279 1.8× 11 1.0k
Heather Mackey United States 6 966 1.8× 200 0.7× 91 0.3× 134 0.6× 207 1.4× 9 1.3k

Countries citing papers authored by Dacita Suen

Since Specialization
Citations

This map shows the geographic impact of Dacita Suen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dacita Suen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dacita Suen more than expected).

Fields of papers citing papers by Dacita Suen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dacita Suen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dacita Suen. The network helps show where Dacita Suen may publish in the future.

Co-authorship network of co-authors of Dacita Suen

This figure shows the co-authorship network connecting the top 25 collaborators of Dacita Suen. A scholar is included among the top collaborators of Dacita Suen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dacita Suen. Dacita Suen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Bryan, Thomas Yau, Roland Leung, et al.. (2021). Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers. Advances in Therapy. 38(12). 5752–5762.
2.
Chiu, Joanne, Roland Leung, Vikki Tang, et al.. (2019). Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy. Postgraduate Medical Journal. 95(1121). 155–161. 4 indexed citations
3.
Kwong, Ava, Dacita Suen, Miranda Chan, et al.. (2019). Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism. Psycho-Oncology. 28(6). 1243–1251. 36 indexed citations
4.
Foo, CC, Simon S.M. Ng, Ava Kwong, et al.. (2019). The role of metacognition and its indirect effect through cognitive attentional syndrome on fear of cancer recurrence trajectories: A longitudinal study. Psycho-Oncology. 29(2). 271–279. 22 indexed citations
5.
Wong, T, et al.. (2019). Sentinel Lymph Node Biopsy in Early Breast Cancer: Magnetic Tracer as the Only Localizing Agent. World Journal of Surgery. 43(8). 1991–1996. 17 indexed citations
6.
Lam, Wwt, Sungwon Yoon, Wai-Man Sze, et al.. (2016). Comparing the meanings of living with advanced breast cancer between women resilient to distress and women with persistent distress: a qualitative study. Psycho-Oncology. 26(2). 255–261. 29 indexed citations
7.
Suen, Dacita, et al.. (2015). Identifying risk factors for brain metastasis in breast cancer patients: Implication for a vigorous surveillance program. Asian Journal of Surgery. 38(4). 220–223. 17 indexed citations
8.
Lam, Wwt, Winnie Yeo, Joyce Suen, et al.. (2015). Goal adjustment influence on psychological well‐being following advanced breast cancer diagnosis. Psycho-Oncology. 25(1). 58–65. 27 indexed citations
9.
Lam, Wwt, Janice Tsang, Winnie Yeo, et al.. (2013). The evolution of supportive care needs trajectories in women with advanced breast cancer during the 12 months following diagnosis. Supportive Care in Cancer. 22(3). 635–644. 38 indexed citations
10.
Lam, Wwt, Miranda Chan, Amy Or, et al.. (2013). Reducing Treatment Decision Conflict Difficulties in Breast Cancer Surgery: A Randomized Controlled Trial. Journal of Clinical Oncology. 31(23). 2879–2885. 93 indexed citations
11.
Chau, Wai‐Wang, et al.. (2012). Triple Negative Status is a Poor Prognostic Indicator in Chinese Women with Breast Cancer: a Ten Year Review. Asian Pacific Journal of Cancer Prevention. 13(5). 2109–2114. 17 indexed citations
12.
Au, Angel Hoe-chi, Wwt Lam, Janice Tsang, et al.. (2012). Supportive care needs in Hong Kong Chinese women confronting advanced breast cancer. Psycho-Oncology. 22(5). 1144–1151. 77 indexed citations
13.
Kwong, Ava, et al.. (2010). Choice of Management of Southern Chinese BRCA Mutation Carriers. World Journal of Surgery. 34(7). 1416–1426. 23 indexed citations
14.
Suen, Dacita, et al.. (2009). Telephone pre-anaesthesia assessment for ambulatory breast surgery.. PubMed. 15(3). 179–82. 12 indexed citations
15.
Suen, Dacita, et al.. (2009). Is sentinel lymph node biopsy after neoadjuvant chemotherapy feasible in Chinese patients with invasive breast cancers?. ANZ Journal of Surgery. 79(10). 719–723. 9 indexed citations
16.
Chan, Vivian, US Khoo, Man Sang Wong, et al.. (2008). Localization of hRad9 in breast cancer. BMC Cancer. 8(1). 196–196. 5 indexed citations
17.
Chok, Ksh, et al.. (2007). FACTORS AFFECTING FALSE‐NEGATIVE BREAST SENTINEL NODE BIOPSY IN CHINESE PATIENTS*. ANZ Journal of Surgery. 77(10). 866–869. 2 indexed citations
18.
Suen, Dacita, et al.. (2007). SENSATION RECOVERY IMPROVED BY GREAT AURICULAR NERVE PRESERVATION IN PAROTIDECTOMY: A PROSPECTIVE DOUBLE‐BLIND STUDY. ANZ Journal of Surgery. 77(5). 374–376. 25 indexed citations
19.
Suen, Dacita & Louis W.C. Chow. (2006). Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer. Biomedicine & Pharmacotherapy. 60(6). 293–297. 6 indexed citations
20.
Chan, Sharon, et al.. (2006). TRIAGING REFERRAL TO A SPECIALIST BREAST CLINIC. ANZ Journal of Surgery. 76(5). 310–312. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026